Ameritas Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$90.7K Hold
371
– – ﹤0.01% 1193
2026
Q2
$75.4K Buy
+371
New +$69.8K ﹤0.01% 1200
2025
Q4
– Sell
-150
Closed -$24.9K – 1019
2025
Q3
$24.9K Sell
150
-221
-60% -$36K ﹤0.01% 1367
2025
Q2
$56.9K Buy
+371
New +$55.3K ﹤0.01% 1245
2023
Q2
– Sell
-371
Closed -$60.6K – 708
2023
Q1
$60.6K Buy
+371
New +$60K ﹤0.01% 1196

Other funds holding BBH

Ameritas Advisory Services's BBH Position: Q3 2026 in Review

Ameritas Advisory Services held its VanEck Biotech ETF (BBH) position steady in Q3 2026 at 371 shares worth $90.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Ameritas Advisory Services first reported a position in BBH in Q1 2023 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

  • Ameritas Advisory Services held 371 shares of VanEck Biotech ETF worth $90.7K as of Q3 2026.
  • Ameritas Advisory Services left its VanEck Biotech ETF share count unchanged in Q3 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q3 2026, its #1193 holding.
  • Ameritas Advisory Services first reported a position in VanEck Biotech ETF in Q1 2023 and has held it in 5 quarters since.
  • 103 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on Ameritas Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.